TrialCardiovascular drugs and therapy2024

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.

Alexander Lenard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.